Literature DB >> 10394382

Progress of the Proton-Ion Medical Machine Study (PIMMS).

P J Bryant1.   

Abstract

The Proton-Ion Medical Machine Study (PIMMS) was set up following an agreement between Professor M. Regler of the Med-AUSTRON (Austria) and Professor U. Amaldi of the TERA Foundation (Italy) to join their efforts in the design of a medical synchrotron that could later be adapted to individual national needs. CERN agreed to host this study inside its PS Division and to contribute one full-time member to the study team. The study group has worked in collaboration with GSI (Germany) and was more recently joined by Onkologie 2000 (Czech Republic). Work started in January 1996 and is expected to finish during 1998. The agreed aim of the study was to investigate and design a generic facility that would allow the direct clinical comparison of protons and carbon ions for cancer treatment. The accelerator was to be designed primarily for high-precision active beam scanning with both protons and ions, but was also to be capable of delivering proton beams with passive spreading.

Entities:  

Mesh:

Year:  1999        PMID: 10394382     DOI: 10.1007/bf03038873

Source DB:  PubMed          Journal:  Strahlenther Onkol        ISSN: 0179-7158            Impact factor:   3.621


  4 in total

1.  Aspects of medical physics of Med-Austron.

Authors:  U Haverkamp
Journal:  Strahlenther Onkol       Date:  1999-06       Impact factor: 3.621

2.  Dreams, themes and particle beams--an oncologist's perspective on technology trickle-down from the LHC.

Authors:  R Jena
Journal:  Br J Radiol       Date:  2014-02-03       Impact factor: 3.039

3.  Study of the magnets used for a mobile isocenter carbon ion gantry.

Authors:  Jhonnatan Osorio Moreno; Marco G Pullia; Cristiana Priano; Valeria Lante; Monica M Necchi; Simone Savazzi
Journal:  J Radiat Res       Date:  2013-07       Impact factor: 2.724

Review 4.  Future Developments in Charged Particle Therapy: Improving Beam Delivery for Efficiency and Efficacy.

Authors:  Jacinta Yap; Andrea De Franco; Suzie Sheehy
Journal:  Front Oncol       Date:  2021-12-09       Impact factor: 5.738

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.